Bailard Inc. Sells 3,861 Shares of Procter & Gamble Company (The) $PG

Bailard Inc. trimmed its holdings in shares of Procter & Gamble Company (The) (NYSE:PG) by 2.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 153,953 shares of the company’s stock after selling 3,861 shares during the period. Bailard Inc.’s holdings in Procter & Gamble were worth $23,655,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. MOKAN Wealth Management Inc. boosted its stake in shares of Procter & Gamble by 13.7% in the second quarter. MOKAN Wealth Management Inc. now owns 15,319 shares of the company’s stock valued at $2,442,000 after buying an additional 1,846 shares during the period. Czech National Bank grew its holdings in shares of Procter & Gamble by 3.8% during the 3rd quarter. Czech National Bank now owns 594,914 shares of the company’s stock worth $91,409,000 after purchasing an additional 21,825 shares in the last quarter. Vega Investment Solutions increased its position in shares of Procter & Gamble by 1.3% in the second quarter. Vega Investment Solutions now owns 638,400 shares of the company’s stock worth $101,710,000 after purchasing an additional 8,500 shares during the period. Westerkirk Capital Inc. acquired a new position in Procter & Gamble in the second quarter valued at about $4,796,000. Finally, Caliber Wealth Management LLC KS lifted its position in Procter & Gamble by 36.2% during the second quarter. Caliber Wealth Management LLC KS now owns 17,798 shares of the company’s stock worth $2,836,000 after purchasing an additional 4,730 shares during the period. Institutional investors own 65.77% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Raymond James Financial decreased their target price on shares of Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a report on Monday, October 20th. Wells Fargo & Company lowered their price objective on shares of Procter & Gamble from $170.00 to $158.00 and set an “overweight” rating for the company in a research report on Monday, January 5th. Bank of America reduced their target price on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. Piper Sandler began coverage on Procter & Gamble in a research note on Wednesday, January 7th. They issued a “neutral” rating and a $150.00 price objective on the stock. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Procter & Gamble in a research note on Monday, December 29th. Fifteen investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $168.36.

Insider Transactions at Procter & Gamble

In other news, CAO Matthew W. Janzaruk sold 725 shares of the firm’s stock in a transaction on Thursday, October 30th. The shares were sold at an average price of $149.57, for a total transaction of $108,438.25. Following the completion of the transaction, the chief accounting officer owned 979 shares of the company’s stock, valued at approximately $146,429.03. This trade represents a 42.55% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.20% of the company’s stock.

Key Stories Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: PG outperformed the broader market on a down day, suggesting defensive demand for its dividend and consumer staples exposure. Coca-Cola and Procter & Gamble outperform on a bruising day overall for US stocks
• Positive Sentiment: Barclays raised its price target on PG to $155 (from $151) — a modest positive signal and described as a “flight to safety,” which can support the stock as investors look for reliable dividend payers. P&G Gets Target Hike as Barclays Calls Move a “Flight to Safety”
• Positive Sentiment: Analysts note P&G’s ongoing productivity initiatives (cost savings, supply-chain efficiencies) that could help protect margins and support EPS if inflationary input costs persist — a structural positive for margins if delivered. Can PG’s Productivity Drive Fuel EPS Gains Amid Inflation?
• Neutral Sentiment: A Motley Fool piece comparing Coca-Cola and P&G highlights both firms’ strong dividend track records; the comparison supports PG’s defensive dividend appeal but doesn’t create immediate upside. I Predicted Coca-Cola Was a Better Buy Than Procter & Gamble in 2025, and I Was Right. Here Is My New Prediction for 2026.
• Neutral Sentiment: PG appears in coverage of high-dividend Dow names (“Dogs of the Dow”), underscoring income investor interest but not signaling near-term fundamental change. The Dogs of the Dow: 10 Downtrodden Dividends Paying Out Up to 6.8%
• Neutral Sentiment: Jim Cramer said he doesn’t expect “fireworks” from PG’s upcoming earnings, which tempers expectations but is not a firm sell signal. Jim Cramer on Procter & Gamble’s Earnings: “I Don’t Expect Any Fireworks or Anything”
• Negative Sentiment: UBS expects a muted fiscal Q2 for PG and models EPS slightly below consensus, signaling the quarter may disappoint and weigh on near-term share performance if the print confirms softness. P&G faces muted fiscal Q2, UBS analysts see recovery in second half
• Negative Sentiment: A Q2 preview highlights margin pressure from commodities, tariffs and competition — risks that could blunt upside to revenue and EPS in the near term. Procter & Gamble Q2 Earnings Preview: Buy Now or Stay Cautious?

Procter & Gamble Trading Up 1.7%

Shares of PG stock opened at $146.96 on Wednesday. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $179.99. The stock’s fifty day simple moving average is $144.67 and its 200 day simple moving average is $150.70. The company has a quick ratio of 0.51, a current ratio of 0.71 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $343.40 billion, a P/E ratio of 21.45, a P/E/G ratio of 4.89 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Friday, October 24th. The company reported $1.99 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The firm had revenue of $22.39 billion for the quarter, compared to analyst estimates of $22.23 billion. During the same period last year, the firm posted $1.93 earnings per share. The business’s revenue for the quarter was up 3.0% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, sell-side analysts predict that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, February 17th. Shareholders of record on Friday, January 23rd will be issued a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend is Friday, January 23rd. Procter & Gamble’s payout ratio is presently 61.75%.

Procter & Gamble Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.